Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012

Antimicrobial Agents and Chemotherapy
Larissa MayRamanan Laxminarayan

Abstract

Coagulase-negative staphylococci (CoNS) are important bloodstream pathogens that are typically resistant to multiple antibiotics. Despite the concern about increasing resistance, there have been no recent studies describing the national prevalence of CoNS pathogens. We used national resistance data over a period of 13 years (1999 to 2012) from The Surveillance Network (TSN) to determine the prevalence of and assess the trends in resistance for Staphylococcus epidermidis, the most common CoNS pathogen, and all other CoNS pathogens. Over the course of the study period, S. epidermidis resistance to ciprofloxacin and clindamycin increased steadily from 58.3% to 68.4% and from 43.4% to 48.5%, respectively. Resistance to levofloxacin increased rapidly from 57.1% in 1999 to a high of 78.6% in 2005, followed by a decrease to 68.1% in 2012. Multidrug resistance for CoNS followed a similar pattern, and this rise and small decline in resistance were found to be strongly correlated with levofloxacin prescribing patterns. The resistance patterns were similar for the aggregate of CoNS pathogens. The results from our study demonstrate that the antibiotic resistance in CoNS pathogens has increased significantly over the past 13 years. These re...Continue Reading

References

Mar 25, 1999·Clinical Therapeutics·J M Blondeau
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M B EdmondR P Wenzel
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D F SahmG Piazza
Sep 13, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D C Hooper
Feb 24, 2001·International Journal of Antimicrobial Agents·P C Appelbaum, P A Hunter
Aug 15, 2003·The Journal of Antimicrobial Chemotherapy·Mark W Garrison
Jun 21, 2005·Emerging Infectious Diseases·Matthew J KuehnertDaniel B Jernigan
Jul 16, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Susan E BeekmannGary V Doern
Apr 12, 2006·Archives of Ophthalmology·Darlene MillerHarry W Flynn
Sep 30, 2006·The Lancet Infectious Diseases·Ari RobicsekDavid C Hooper
Feb 9, 2008·Emerging Infectious Diseases·Eili KleinRamanan Laxminarayan
Nov 7, 2008·Veterinary Microbiology·A Piette, G Verschraegen
Dec 17, 2008·International Journal of Antimicrobial Agents·Shih-Ming TsaoPo-Ren Hsueh
Jan 13, 2009·Infectious Disease Clinics of North America·Kathie L RogersMark E Rupp
May 14, 2009·The Journal of Antimicrobial Chemotherapy·Majdi N Al-HasanLarry M Baddour
Dec 25, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Marc S HoffmannRamanan Laxminarayan
Oct 5, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·José Manuel Rodríguez-MartínezAlvaro Pascual
Apr 6, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G DimitriouS Mantagos
Nov 19, 2011·Seminars in Immunopathology·Michael Otto
Nov 30, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E AhlstrandB Söderquist
Apr 3, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M RahkonenT Hautala
Jun 13, 2012·Antimicrobial Agents and Chemotherapy·Rodrigo E MendesDavid J Farrell
Jul 4, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lova SunRamanan Laxminarayan
Jul 6, 2012·The American Journal of Cardiology·Katherine Y LeUNKNOWN Mayo Cardiovascular Infections Study Group
Feb 8, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Nikolay P BraykovRamanan Laxminarayan

❮ Previous
Next ❯

Citations

Aug 8, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Malihe TalebiMohammad R Pourshafie
Dec 2, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Luiza PinheiroMaria Lourdes Ribeiro Souza Cunha
Sep 14, 2015·Journal of Dairy Science·Maged El-AshkerHelmut Hotzel
Jul 16, 2015·Chembiochem : a European Journal of Chemical Biology·David BarteeCaren L Freel Meyers
Dec 19, 2014·Chemical Biology & Drug Design·Andrew C McShan, Roberto N De Guzman
Apr 28, 2016·The Journal of Antimicrobial Chemotherapy·Ariane DeplanoOlivier Denis
Apr 23, 2016·Gastroenterology·Carlo A FalloneJohn K Marshall
Feb 7, 2018·Frontiers in Cellular and Infection Microbiology·Rebekah M Martin, Michael A Bachman
Jun 1, 2017·Antimicrobial Agents and Chemotherapy·Nethravathi PoonachaUmender Sharma
Aug 11, 2017·PloS One·Frederike M J ReischiesDavid B Lumenta
Jun 4, 2017·The Cochrane Database of Systematic Reviews·Ofrat Beyar-KatzMical Paul
Nov 2, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A JoncourBlandine Rammaert
Feb 12, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jonathan AsanteSabiha Y Essack
Jun 4, 2019·European Journal of Hospital Pharmacy. Science and Practice·Farah Al MadfaiRahul P Patel
May 18, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Ayelet MintzRuben Bromiker
Sep 18, 2020·Expert Opinion on Drug Metabolism & Toxicology·Marzieh DanialiMohammad Abdollahi
Feb 15, 2020·Expert Review of Anti-infective Therapy·Karsten BeckerHolger Rohde
Apr 25, 2020·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Vinícius Pietta PerezPedro Alves d'Azevedo
Mar 3, 2020·Japanese Journal of Infectious Diseases·Yamuna Devi BakthavatchalamBalaji Veeraraghavan
May 7, 2020·Journal of Chemotherapy·Yasser Musa Ibrahim, Wael Mohamed Abu El-Wafa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.